UniProt ID | UBA5_HUMAN | |
---|---|---|
UniProt AC | Q9GZZ9 | |
Protein Name | Ubiquitin-like modifier-activating enzyme 5 | |
Gene Name | UBA5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 404 | |
Subcellular Localization | Cytoplasm . Nucleus . Golgi apparatus . Localizes mainly in the cytoplasm, while it localizes to the nucleus in presence of SUMO2 (PubMed:18442052). | |
Protein Description | E1-like enzyme which activates UFM1 and SUMO2.. | |
Protein Sequence | MAESVERLQQRVQELERELAQERSLQVPRSGDGGGGRVRIEKMSSEVVDSNPYSRLMALKRMGIVSDYEKIRTFAVAIVGVGGVGSVTAEMLTRCGIGKLLLFDYDKVELANMNRLFFQPHQAGLSKVQAAEHTLRNINPDVLFEVHNYNITTVENFQHFMDRISNGGLEEGKPVDLVLSCVDNFEARMTINTACNELGQTWMESGVSENAVSGHIQLIIPGESACFACAPPLVVAANIDEKTLKREGVCAASLPTTMGVVAGILVQNVLKFLLNFGTVSFYLGYNAMQDFFPTMSMKPNPQCDDRNCRKQQEEYKKKVAALPKQEVIQEEEEIIHEDNEWGIELVSEVSEEELKNFSGPVPDLPEGITVAYTIPKKQEDSVTELTVEDSGESLEDLMAKMKNM | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MAESVERLQQR ----CHHHHHHHHHH | 21.53 | 24719451 | |
14 | Ubiquitination | RLQQRVQELERELAQ HHHHHHHHHHHHHHH | 50.14 | 24816145 | |
42 | Ubiquitination | GGRVRIEKMSSEVVD CCCEEEEECCCCCCC | 41.53 | 24816145 | |
43 | Sulfoxidation | GRVRIEKMSSEVVDS CCEEEEECCCCCCCC | 3.28 | 21406390 | |
44 | Phosphorylation | RVRIEKMSSEVVDSN CEEEEECCCCCCCCC | 34.12 | 25850435 | |
45 | Phosphorylation | VRIEKMSSEVVDSNP EEEEECCCCCCCCCH | 30.80 | 21082442 | |
50 | Phosphorylation | MSSEVVDSNPYSRLM CCCCCCCCCHHHHHH | 28.26 | 22210691 | |
51 | Ubiquitination | SSEVVDSNPYSRLMA CCCCCCCCHHHHHHH | 34.76 | 29967540 | |
53 | Phosphorylation | EVVDSNPYSRLMALK CCCCCCHHHHHHHHH | 15.63 | 22461510 | |
66 | Phosphorylation | LKRMGIVSDYEKIRT HHHCCCCCCHHHHHH | 32.33 | 20068231 | |
68 | Phosphorylation | RMGIVSDYEKIRTFA HCCCCCCHHHHHHHE | 16.18 | 20068231 | |
70 | Ubiquitination | GIVSDYEKIRTFAVA CCCCCHHHHHHHEEE | 31.12 | 24816145 | |
99 | Ubiquitination | LTRCGIGKLLLFDYD HHHCCCCCEEEECCC | 33.76 | - | |
107 | Ubiquitination | LLLFDYDKVELANMN EEEECCCHHHHCCHH | 31.23 | 29967540 | |
127 | Ubiquitination | PHQAGLSKVQAAEHT HHHCCCHHHHHHHHH | 43.33 | - | |
134 | Phosphorylation | KVQAAEHTLRNINPD HHHHHHHHHHHCCCC | 20.93 | 28857561 | |
173 | Acetylation | NGGLEEGKPVDLVLS CCCCCCCCCCCEEEE | 45.18 | 26051181 | |
173 | Ubiquitination | NGGLEEGKPVDLVLS CCCCCCCCCCCEEEE | 45.18 | - | |
190 | Phosphorylation | DNFEARMTINTACNE CCCHHHHHHHHHHHH | 12.91 | 28176443 | |
193 | Phosphorylation | EARMTINTACNELGQ HHHHHHHHHHHHHHH | 28.83 | 28176443 | |
201 | Phosphorylation | ACNELGQTWMESGVS HHHHHHHHHHHCCCC | 25.61 | 28176443 | |
205 | Phosphorylation | LGQTWMESGVSENAV HHHHHHHCCCCCCCC | 28.52 | 28176443 | |
208 | Phosphorylation | TWMESGVSENAVSGH HHHHCCCCCCCCCCE | 28.76 | 28176443 | |
213 | Phosphorylation | GVSENAVSGHIQLII CCCCCCCCCEEEEEE | 23.42 | 28176443 | |
224 | Phosphorylation | QLIIPGESACFACAP EEEECCCCCCCCCCC | 35.93 | 28176443 | |
264 | Ubiquitination | TMGVVAGILVQNVLK CHHHHHHHHHHHHHH | 2.16 | 22817900 | |
265 | Ubiquitination | MGVVAGILVQNVLKF HHHHHHHHHHHHHHH | 2.95 | 22817900 | |
286 | Ubiquitination | VSFYLGYNAMQDFFP HHEEECHHHHHHHCC | 27.43 | 22817900 | |
287 | Ubiquitination | SFYLGYNAMQDFFPT HEEECHHHHHHHCCC | 6.63 | 22817900 | |
296 | Phosphorylation | QDFFPTMSMKPNPQC HHHCCCCCCCCCCCC | 26.57 | 24719451 | |
320 | Ubiquitination | EEYKKKVAALPKQEV HHHHHHHHHCCHHHH | 16.50 | 22817900 | |
321 | Ubiquitination | EYKKKVAALPKQEVI HHHHHHHHCCHHHHH | 27.64 | 22817900 | |
350 | Phosphorylation | IELVSEVSEEELKNF EEEEEECCHHHHHCC | 34.93 | 21815630 | |
358 | Phosphorylation | EEELKNFSGPVPDLP HHHHHCCCCCCCCCC | 52.13 | 21945579 | |
369 | Phosphorylation | PDLPEGITVAYTIPK CCCCCCEEEEEECCC | 15.22 | 21945579 | |
372 | Phosphorylation | PEGITVAYTIPKKQE CCCEEEEEECCCCCC | 10.81 | 21945579 | |
373 | Phosphorylation | EGITVAYTIPKKQED CCEEEEEECCCCCCC | 22.52 | 21945579 | |
376 | Ubiquitination | TVAYTIPKKQEDSVT EEEEECCCCCCCCCE | 64.34 | 22817900 | |
377 | Ubiquitination | VAYTIPKKQEDSVTE EEEECCCCCCCCCEE | 54.27 | 22817900 | |
381 | Phosphorylation | IPKKQEDSVTELTVE CCCCCCCCCEEEEEE | 30.13 | 21712546 | |
383 | Phosphorylation | KKQEDSVTELTVEDS CCCCCCCEEEEEECC | 29.27 | 18669648 | |
386 | Phosphorylation | EDSVTELTVEDSGES CCCCEEEEEECCCCC | 18.67 | 21712546 | |
390 | Phosphorylation | TELTVEDSGESLEDL EEEEEECCCCCHHHH | 30.84 | 21712546 | |
393 | Phosphorylation | TVEDSGESLEDLMAK EEECCCCCHHHHHHH | 40.35 | 28192239 | |
398 | Sulfoxidation | GESLEDLMAKMKNM- CCCHHHHHHHHHCC- | 5.36 | 21406390 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of UBA5_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UBA5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBA5_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45, AND MASSSPECTROMETRY. |